Randomized trial evaluates human-guided machine learning for enhancing patient-reported outcomes in renal cancer patients, suggesting a more inclusive research approach.
Objectives/Goals: To evaluate the extent to which characterization of unstructured patient-generated health data (UPGD) (e.g., health journals) with human-guided machine learning (HGML) improves model explainability and integrates patient voices among renal cancer patients in a randomized control trial (RCT). Methods/Study Population: Data were collected in an RCT (NCT00505310) assessing the benefits of an emotional expression intervention on renal cancer patients’ quality-of-life outcomes. Over a 10-day period, patients completed four journal-type written responses to structured prompts about their health lifestyle behaviors or deepest thoughts and feelings linked to cancer. I will 1) evaluate the extent to which a standard ML model versus an HGML model aligns with principles of trustworthy health AI when characterizing UPGD, 2) evaluate the extent to which UPGD captures condition-specific data complementary to PROMs, and 3) extract journey maps from narratives about patient experiences navigating cancer care. Results/Anticipated Results: Results will illustrate a patient-centered value research approach that centers patient perspectives, contextualizes heterogeneous factors influencing patient outcomes, and mitigates biases in the health research machine learning pipeline. Discussion/Significance of Impact: This research contributes to the development of evidence-based and empirically validated strategies for health researchers to incorporate explainable HGML tools that facilitate the inclusion of patients’ experiences, perspectives, needs, and priorities throughout the research process.
No takes yet. Share an insight, caveat, or question.
Brenda Amezquita-Castro (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: